Lenvatinib 4mg and 10mg are oral capsule strengths containing the active medicine lenvatinib. It belongs to a group of medicines called kinase inhibitors and works by blocking several signaling pathways involved in blood-vessel formation and cancer-cell growth.
Lenvatinib may be prescribed for certain cancers, depending on the patient’s diagnosis and treatment plan. Its approved uses include progressive radioactive iodine-refractory differentiated thyroid cancer. It can also be used with other medicines for selected patients with advanced renal cell carcinoma and endometrial cancer. Lenvatinib is also used alone for certain cases of unresectable hepatocellular carcinoma.
How Lenvatinib Works
Lenvatinib targets specific kinases, including VEGF receptors, which are involved in processes that support tumor growth and new blood vessel development. By interfering with these pathways, the medicine can help slow cancer progression in appropriate patients.
Lenvatinib 4mg and 10mg Strengths
The 4mg and 10mg capsules provide flexible strengths that doctors can use when selecting or adjusting an appropriate daily dose. The required dose varies according to the cancer being treated, combination medicines, body weight, and individual health factors. Therefore, patients should take lenvatinib exactly as prescribed rather than selecting a strength themselves.
Important Safety Information
Lenvatinib requires regular medical monitoring because treatment can cause significant adverse effects. High blood pressure is an important concern, while other serious risks can involve heart function, blood vessels, kidney function, liver function, and protein loss in urine.
Patients should tell their healthcare provider about existing medical conditions and all medicines they use before starting treatment. Never change the dose, stop treatment, or combine lenvatinib with another cancer medicine without medical guidance.